4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ·Healthcare·Biotechnology
$9.49
+0.42%
Mkt Cap $479.88M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $27.00M | $85.10M | +215.20% | -$0.53 | $0.43 | +181.13% | — | — |
| Q4 2025 Nov 10, 2025 | $30.86M | $90.00K | -99.71% | -$1.02 | -$1.01 | +0.98% | — | — |
| Q3 2025 Aug 11, 2025 | $4.67K | $15.00K | +221.20% | -$0.88 | -$0.98 | -11.36% | — | — |
| Q2 2025 May 8, 2025 | $537.50K | $14.00K | -97.40% | -$0.84 | -$0.86 | -2.38% | — | — |
| Q1 2025 Feb 28, 2025 | $2.28M | $1.00K | -99.96% | -$0.80 | -$0.90 | -12.50% | — | — |
| Q4 2024 Nov 13, 2024 | $2.20M | $3.00K | -99.86% | -$0.67 | -$0.79 | -17.91% | — | — |
| Q3 2024 Aug 8, 2024 | $1.31M | $5.00K | -99.62% | -$0.72 | -$0.63 | +12.50% | — | — |
| Q2 2024 May 9, 2024 | $780.00K | $28.00K | -96.41% | -$0.73 | -$0.66 | +9.59% | — | — |
| Q1 2024 Feb 29, 2024 | $2.40M | $19.00K | -99.21% | -$0.68 | -$0.77 | -13.24% | — | — |
| Q4 2023 Nov 9, 2023 | $2.06M | $20.20M | +880.78% | -$0.67 | -$0.24 | +64.18% | — | — |
| Q3 2023 Aug 9, 2023 | $850.00K | $239.00K | -71.88% | -$0.77 | -$0.77 | +0.00% | — | — |
| Q2 2023 May 10, 2023 | $1.03M | $298.00K | -71.07% | -$0.88 | -$0.88 | +0.00% | — | — |
| Q1 2023 Mar 15, 2023 | $3.01M | $1.25M | -58.57% | -$0.75 | -$0.84 | -12.00% | — | — |
| Q4 2022 Nov 8, 2022 | $376.25K | $500.00K | +32.89% | -$0.85 | -$0.79 | +7.06% | — | — |
| Q3 2022 Aug 11, 2022 | $856.00K | $162.00K | -81.07% | -$0.78 | -$0.87 | -11.54% | — | — |
| Q2 2022 May 12, 2022 | $758.33K | $1.22M | +60.75% | -$0.73 | -$0.82 | -12.33% | — | — |
| Q1 2022 Mar 28, 2022 | $900.00K | $92.00K | -89.78% | -$0.82 | -$0.85 | -3.66% | — | — |
| Q4 2021 Nov 10, 2021 | $1.38M | $1.37M | -1.19% | -$0.83 | -$0.82 | +1.20% | — | — |
| Q3 2021 Aug 12, 2021 | $14.58M | $14.58M | +0.00% | -$0.71 | -$0.28 | +60.56% | — | — |
| Q2 2021 May 13, 2021 | $2.60M | $2.00M | -23.13% | -$1.10 | -$0.61 | +44.55% | — | — |